ISSN 2639-9431
Vol. 7, Issue 4, 2024October 31, 2024 EDT
Self-assembled Human Serum Protein-based Core-shell Nanoparticles to inhibit key oncogenic signalling in Drug-Resistant Leukemia
Self-assembled Human Serum Protein-based Core-shell Nanoparticles to inhibit key oncogenic signalling in Drug-Resistant Leukemia
Archana Payickattu Retnakumary, Lekshmi G Kumar, Neeraj Sidharthan, Pavithran Keechilat, Giridharan L. Malarvizhi, Prasanna L Hanumanthu, Madhavan V Thampi, Deepthy Menon, Krishnakumar Menon, Shantikumar V Nair, Manzoor Koyakutty,
Articles in Vol. 7, Issue 4, 2024
Vol. 7, Issue 4, 2024
- Self-assembled Human Serum Protein-based Core-shell Nanoparticles to inhibit key oncogenic signalling in Drug-Resistant LeukemiaArchana Payickattu RetnakumaryLekshmi G KumarNeeraj SidharthanPavithran KeechilatGiridharan L. MalarvizhiPrasanna L HanumanthuMadhavan V ThampiDeepthy MenonKrishnakumar MenonShantikumar V NairManzoor Koyakutty
- Synthesis and Characterization of 5-Fluoroacil Loaded Calcium Carbonate Nanoparticles for Targeted Cancer TherapyKshidan Marim Abdullah SalemMohamed Ahmed IbrahimKim Wei ChanMd Zuki Abu BakarNoorjahan Banu AlitheenMohammed AlsubbiAhmad Faizal Abdull RazisNorsharina Ismail
- Nanotechnology-Enhanced Controlled Release Systems in Topical TherapeuticsYohannes Teklehaimanot
Payickattu Retnakumary, Archana, Lekshmi G Kumar, Neeraj Sidharthan, Pavithran Keechilat, Giridharan L. Malarvizhi, Prasanna L Hanumanthu, Madhavan V Thampi, et al. 2024. “Self-Assembled Human Serum Protein-Based Core-Shell Nanoparticles to Inhibit Key Oncogenic Signalling in Drug-Resistant Leukemia.” Precision Nanomedicine 7 (4): 1348–64. https://doi.org/10.33218/001c.125335.